.
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
. is the place to come for breaking news, analysis and for stories that are just too interesting � or too entertaining � to pass up.
.
.